Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts ...

Barclays raises British American Tobacco price target to 3,550 (3,250) pence - 'overweight' Bank of America cuts Rolls-Royce price target to 830 (850) pence - 'buy' Barclays cuts Hiscox price target ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...

Stock markets mostly fell, the dollar slid and gold hit a record high Wednesday over fears about a trade war between ...

GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.

Wellnex is undertaking a $16 million capital raising ahead of a dual listing on London's AIM exchange, a focal point for European expansion.

Pharmaceutical giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drug pipeline. It came as the boss of the London-listed firm cheered an “excellent” performance ...

In early UK corporate news, GSK announced a buyback and upped its 2031 sales target. Here is what you need to know at the London market open: FTSE 100: called down 0.3% at 8,542.57 Hang Seng: down 1.0 ...

Pharmaceutical giant GSK has hiked its 2031 sales forecast to more than £40bn, up from £38bn, after reporting better than ...

European markets opened mixed on Wednesday, with investors looking ahead to more earnings from a number of key companies.

The UK biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.